NCT01497145

A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome

A Phase 2, Randomized, Open-Label, Parallel, Comparative, Dose-Response Study to Evaluate the Efficacy and Safety of KRN321 in Adult Subjects With Low- or Intermediate-1-Risk Myelodysplastic Syndrome

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 45 (estimated)
• Sponsor: Kyowa Kirin Co., Ltd. · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, Randomized, Open-Label, Parallel, Comparative, Dose-Response Study to Evaluate the Efficacy and Safety study of KRN321 of subcutaneous injection in Adult Subjects with Low- or Intermediate-1-Risk Myelodysplastic Syndrome.

Conditions

• MDS

Interventions

Type	Name	Description
DRUG	KRN321

Timeline

• Start date: 2011-12-01
• Primary completion: 2014-02-01
• Completion: 2014-02-01
• First posted: 2011-12-22
• Last updated: 2015-03-04

Locations

2 sites across 2 countries: Japan, South Korea